{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:41:58Z","timestamp":1770752518277,"version":"3.50.0"},"reference-count":24,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1303,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1111\/j.1600-0404.2012.01643.x","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T19:47:36Z","timestamp":1328557656000},"page":"287-291","source":"Crossref","is-referenced-by-count":16,"title":["Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO"],"prefix":"10.1155","volume":"126","author":[{"given":"J.-H.","family":"Min","sequence":"first","affiliation":[{"name":"Department of Neurology; Samsung Medical Center; School of Medicine; Sungkyunkwan University; Seoul; Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Waters","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences; Neuroimmunology group; John Radcliffe Hospital; Oxford; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vincent","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences; Neuroimmunology group; John Radcliffe Hospital; Oxford; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology; Samsung Medical Center; School of Medicine; Sungkyunkwan University; Seoul; Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Y. Shin","sequence":"additional","affiliation":[{"name":"Center for Health Promotion; Samsung Medical Center; School of Medicine; Sungkyunkwan University; Seoul; Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"H. Lee","sequence":"additional","affiliation":[{"name":"Department of Neurology; Samsung Medical Center; School of Medicine; Sungkyunkwan University; Seoul; Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Neurology; Samsung Medical Center; School of Medicine; Sungkyunkwan University; Seoul; Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,2,6]]},"reference":[{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0001|ane1643-cit-0001","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.94.6.2528","article-title":"Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis","volume":"94","author":"Hooper","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0002|ane1643-cit-0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-3639.1999.tb00212.x","article-title":"Demyelination: the role of reactive oxygen and nitrogen species","volume":"9","author":"Smith","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0003|ane1643-cit-0003","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1191\/1352458504ms1042oa","article-title":"Serum uric acid levels in optic neuritis","volume":"10","author":"Knapp","year":"2004","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0004|ane1643-cit-0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clineuro.2005.08.004","article-title":"Serum uric acid and multiple sclerosis","volume":"108","author":"Rentzos","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0005|ane1643-cit-0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0361-9230(94)90285-2","article-title":"Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation","volume":"33","author":"Church","year":"1994","journal-title":"Brain Res Bull"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0006|ane1643-cit-0006","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer's disease","volume":"21","author":"Kim","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0007|ane1643-cit-0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2004.12.008","article-title":"Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses","volume":"231","author":"Mostert","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0008|ane1643-cit-0008","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004150170246","article-title":"Uric acid levels in sera from patients with multiple sclerosis","volume":"248","author":"Drulovic","year":"2001","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0009|ane1643-cit-0009","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-1331.2008.02087.x","article-title":"Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment","volume":"15","author":"Guerrero","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0010|ane1643-cit-0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0003-9861(91)90224-7","article-title":"Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide","volume":"288","author":"Radi","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0011|ane1643-cit-0011","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0012|ane1643-cit-0012","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00415-010-5455-1","article-title":"Serum uric acid levels and neuromyelitis optica","volume":"257","author":"Peng","year":"2010","journal-title":"J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0013|ane1643-cit-0013","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0014|ane1643-cit-0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"Mcdonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0015|ane1643-cit-0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0016|ane1643-cit-0016","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0017|ane1643-cit-0017","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0018|ane1643-cit-0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-9255-6-18","article-title":"TNF-alpha and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica","volume":"6","author":"Penton-Rol","year":"2009","journal-title":"J Inflamm (Lond)"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0019|ane1643-cit-0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2004.09.002","article-title":"The pathology of multiple sclerosis","volume":"23","author":"Lucchinetti","year":"2005","journal-title":"Neurol Clin"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0020|ane1643-cit-0020","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/092986705774462833","article-title":"Anti-inflammatory immunotherapy for multiple sclerosis\/experimental autoimmune encephalomyelitis (EAE) disease","volume":"12","author":"Kanwar","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0021|ane1643-cit-0021","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458507082143","article-title":"Serum uric acid levels of patients with multiple sclerosis and other neurological diseases","volume":"14","author":"Peng","year":"2008","journal-title":"Mult Scler"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0022|ane1643-cit-0022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","article-title":"Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction","volume":"9","author":"Toncev","year":"2002","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0023|ane1643-cit-0023","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000227277","article-title":"Interferon-beta(1b) treatment in neuromyelitis optica","volume":"62","author":"Tanaka","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1111\/j.1600-0404.2012.01643.x-BIB1643-bib-0024|ane1643-cit-0024","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.0b013e3181f88191","article-title":"Prevalence of multiple sclerosis in Korea","volume":"75","author":"Kim","year":"2010","journal-title":"Neurology"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2012.01643.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.2012.01643.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:50:28Z","timestamp":1671540628000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.2012.01643.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,6]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.2012.01643.x","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,6]]}}}